Financhill
Back

Biohaven Quote, Financials, Valuation and Earnings

Biohaven Price Quote

$36.21
-0.05 (2.46%)
(Updated: December 21, 2024 at 5:17 AM ET)

Biohaven Key Stats

Sell
12
Biohaven (BHVN) is a Sell

Day range:
$34.46 - $36.95
52-week range:
$26.80 - $62.21
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
11.6%

Volume:
3.1M
Avg. volume:
1M
1-year change:
-4.38%
Market cap:
$3.7B
Revenue:
$0
EPS:
$-9.41

How Much Does Biohaven Make?

Data Unavailable

Is Biohaven Growing As A Company?

Data Unavailable

Biohaven Stock Price Performance

  • Did Biohaven Stock Go Up Last Month?
    Biohaven share price went down by -22.57% last month
  • Did BHVN's Share Price Rise Over The Last Year?
    BHVN share price fell by -4.38% over the past 1 year

What Is Biohaven 52-Week High & Low?

  • What Is Biohaven’s 52-Week High Share Price?
    Biohaven has traded as high as $62.21 over the past 52 weeks
  • What Is Biohaven’s 52-Week Low Share Price?
    Biohaven has traded as low as $26.80 over the past 52 weeks

Biohaven Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biohaven?

Data Unavailable

Is Biohaven Cash Flow Positive?

Data Unavailable

Biohaven Return On Invested Capital

Data Unavailable

Biohaven Earnings Date & Stock Price

  • What Is Biohaven's Stock Price Today?
    A single share of BHVN can be purchased today for 36.26
  • What Is Biohaven’s Stock Symbol?
    Biohaven trades on the nyse under the ticker symbol: BHVN
  • When Is Biohaven’s Next Earnings Date?
    The next quarterly earnings date for Biohaven is scheduled on February 28, 2025
  • When Is BHVN's next ex-dividend date?
    Biohaven's next ex-dividend date is December 21, 2024
  • How To Buy Biohaven Stock?
    You can buy Biohaven shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biohaven Competitors

  • Who Are Biohaven's Competitors?
    Below is a list of companies who compete with Biohaven or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Eli Lilly and Co (LLY)
    • Regeneron Pharmaceuticals Inc (REGN)
    • Scholar Rock Holding Corp (SRRK)
    • Veru Inc (VERU)

Biohaven Dividend Yield

Data Unavailable

Biohaven Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -12.21%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable